Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.

<h4>Background & aims</h4>Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are avail...

Full description

Saved in:
Bibliographic Details
Main Authors: Rakesh Aggarwal, Qiushi Chen, Amit Goel, Nicole Seguy, Razia Pendse, Turgay Ayer, Jagpreet Chhatwal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0176503&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!